Realize is a deep learning company specializing in cloud-based SaaS solutions. We design with your workflow in mind. Our new computer-aided detection suite of radiology solutions, powered by deep learning, augment clinicians with an inexpensive and highly accurate additional read. Realize’s CT lung nodule detection application, available soon for investigational use, boasts a nodule miss rate of just 4% at a specificity of 4 false positives per scan. For comparison, a leading FDA-approved competitor has a 21% miss rate at the same specificity, and radiologist miss rates as high as 56% have been documented. We anticipate similar performance in our forthcoming solutions for abnormalities in chest X-ray, pulmonary embolism in CT angiography, and intracranial hemorrhage in head CT. In addition, we are currently developing systems to prioritize scans with algorithmically-suspected pulmonary embolism, or intracranial hemorrhage in emergency work queues, shaving critical minutes off of treatment response times. We are developing novel applications to meet critical clinical needs. They are ideal for all time sensitive environments whether they be limited staffed community based facilities, teleradiology services providing after-hours reads, large healthcare systems, or freestanding urgent care clinics. Realize is a cross industry deep learning company. Contact us to discuss how deep learning can help you.